Detalhe da pesquisa
1.
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study.
J Neurol Neurosurg Psychiatry;
95(2): 125-133, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37748927
2.
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study.
Am J Hematol;
97(4): 421-430, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35015312
3.
Graft-versus-mastocytosis effect after donor lymphocyte infusion: Proof of principle.
Eur J Haematol;
106(2): 290-293, 2021 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33010068
4.
Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study.
Eur J Haematol;
107(6): 617-623, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34418168
5.
Storage-induced change in platelet transfusion response evaluated by serial transfusions from one donor to one patient.
Transfusion;
59(2): 723-728, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30548486
6.
Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
Eur J Haematol;
99(5): 442-448, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28881484
7.
Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.
Eur J Haematol;
98(1): 57-66, 2017 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27428357
8.
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.
Br J Haematol;
169(5): 683-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25817799
9.
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.
Blood;
122(7): 1284-92, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23843494
10.
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006).
Eur J Haematol;
94(3): 243-50, 2015 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25082346
11.
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.
Leukemia;
38(4): 781-787, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38278960
12.
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia.
J Clin Invest;
132(17)2022 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36047494
13.
Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry.
Bone Marrow Transplant;
54(11): 1764-1774, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30962502
14.
Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.
Leukemia;
38(4): 925, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38418611
15.
The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study.
Leukemia;
37(5): 1156-1159, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37037908
16.
Musculoskeletal pain in patients with chronic myeloid leukemia after discontinuation of imatinib: a tyrosine kinase inhibitor withdrawal syndrome?
J Clin Oncol;
32(25): 2821-3, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25071107